Post COVID-19 Vaccine Related Cerebral Venous Sinus Thrombosis and ThrombocytopeniaInternal Medicine Published on 2022-01-042022-10-31 Journal: Cureus [Category] COVID-19, [키워드] cerebral cerebral venous sinus thrombosis (cvst) COVID COVID 19 covid 19 vaccination COVID-19 COVID-19 pandemic effective fatal complication Immune thrombocytopenia morbidity and mortality prevalent prothrombotic Safe Side effect Sinus syndrome the vaccine thrombocytopenia thrombosis thrombosis with thrombocytopenia syndrome (tts) vaccination Vaccine vaccine-induced immune thrombocytopenia and thrombosis (vitt) vaccine-induced prothrombotic immune thrombocytopenia (vipit) while women younger people [DOI] 10.7759/cureus.20932 PMC 바로가기 [Article Type] Internal Medicine
SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in HouseholdSARS-CoV-2 델타 변이형 돌발 감염 및 가정 내 2차 전파Article Published on 2022-01-032022-09-11 Journal: Journal of Korean medical science [Category] 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Asymptomatic attack rate BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine calculated Chain Reaction characterized Clinical severity close contact confirmed case coronavirus coronavirus disease Coronavirus disease 2019 Coverage COVID-19 COVID-19 vaccine Delta delta variant Effectiveness epidemiologic feature groups household infected case infection rate isolate mass vaccination mRNA mRNA vaccine of BNT162b2 outbreak participant Participants polymerase chain polymerase chain reaction reverse transcriptase Reverse transcriptase polymerase chain reaction SAR SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 virus second secondary secondary attack rate secondary transmission severe acute respiratory syndrome Coronavirus South Korea symptomatic case symptomatic cases the vaccine transcriptase Transmissibility vaccination vaccination rate Vaccination Status Vaccine vaccinee variant [DOI] 10.3346/jkms.2022.37.e12 PMC 바로가기 [Article Type] Article
Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 VariantsArticle Published on 2022-01-032022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% CI adverse event blood sample BNT162b2 collected comparable CoronaVac COVID-19 D614G declined Delta variants dose Effectiveness evaluated geometric mean titre GMT group groups heterologous vaccination heterologous vaccine homologous immunogenicity Live virus microneutralization mRNA naïve Neutralization antibody Neutralizing activity neutralizing antibody participant recruited reduced Safe SARS-CoV-2 SARS-CoV-2 variant severe adverse events Strategy the antibody response the mean the SARS-CoV-2 the vaccine Vaccination strategy Vaccine vaccine immunogenicity Vaccines variant variants virus waned wild-type [DOI] 10.3390/vaccines10010072 PMC 바로가기 [Article Type] Article
The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response코로나19 mRNA 백신의 나노입자 기반 성공과 전염병 백신 대응을 위한 마이크로니들 플랫폼의 약속Section B: Infectious Diseases: Pathogenesis, Immune Responses, Vaccines, Diagnostics, and the Broad Impact of Them on Society Published on 2022-01-012022-09-10 Journal: DNA and Cell Biology [Category] 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antigen antigenic antigens approved biomaterials biomaterials and pandemic readiness cargo Cell Community coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 vaccines Critical critical mass Degradation disease effective effort Europe facilitate feature Health crisis immune responses Lipid management medical intervention Microneedle microneedle arrays for vaccination mRNA mRNA vaccine mRNA vaccines nanoparticles and COVID-19 vaccines nucleic acid nucleic acids Outbreaks pandemic Pathogens Perspective promise PROTECT Protective provided public health public health crisis reached readiness regions Research respiratory response SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Spike protein the United State the vaccine the vaccines translated Trigger triggers United States vaccination Vaccine Vaccines [DOI] 10.1089/dna.2021.0538 PMC 바로가기 [Article Type] Section B: Infectious Diseases: Pathogenesis, Immune Responses, Vaccines, Diagnostics, and the Broad Impact of Them on Society
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2SARS-CoV-2에 대한 확장 가능하고 면역원성이 높은 바이러스 유사 입자 기반 백신Article Published on 2022-01-012022-09-11 Journal: Allergy [Category] SARS, 변종, 유전자 메커니즘, 진단, [키워드] added addition antibody Antibody Response Antibody responses Bacterial booster booster injections candidate vaccine caused centrifugation classical convalescent COVID-19 cross-reactive dose effective hand human sera hygiene immunogenic immunologically in some induce Injections long term Masks mice mutant Neutralizing Pandemics purification RBD RBM receptor-binding motif RNA SARS-CoV-2 stability the SARS-CoV-2 the vaccine Vaccine vaccine candidate Vaccines variants variants of concern virus virus-like particles wearing masks while yield [DOI] 10.1111/all.15080 PMC 바로가기 [Article Type] Article
Politicization and COVID-19 vaccine resistance in the U.S미국의 정치화와 코로나19 백신 내성Article Published on 2022-01-012022-09-11 Journal: Progress in molecular biology and translational sc [Category] Coronavirus, SARS, 변종, [키워드] clinician contributed COVID-19 COVID-19 vaccine COVID-19 vaccines Factor Health Hesitancy Impact International limit media Motivated reasoning National offer Politicization positive Practitioner Science social media sound the disease The United States the vaccine United States Vaccine Vaccine acceptance Vaccine resistance. Vaccines Variability variants [DOI] 10.1016/bs.pmbts.2021.10.002 PMC 바로가기 [Article Type] Article
Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: The Israeli case백신 프로그램 10개월 후 델타 COVID-19 변종에 대한 감염성, 중증도 및 백신 효과의 변화: 이스라엘 사례Article Published on 2022-01-012022-09-11 Journal: Preventive medicine [Category] SARS, 변종, [키워드] age approach Case fatality rate change changes in conducted confirmed case confirmed cases country Coverage COVID COVID 19 COVID-19 COVID-19 incidence database death rate death rates Delta delta variant demonstrated Effectiveness epidemiological data Fatality rate groups High Hospitalization Hospitalized Infectious diseases Israel Ministry of Health morbidity morbidity and mortality Mortality much higher PCR-confirmed rates of infection reduced severe cases severity the vaccine vaccination Vaccination Status Vaccine vaccine effectiveness variant variants [DOI] 10.1016/j.ypmed.2021.106890 PMC 바로가기 [Article Type] Article
Willingness to Accept Expedited COVID-19 Vaccine Research for Children Aged <12 Years After Adult Vaccine ApprovalResearch article Published on 2022-01-012022-10-05 Journal: Clinical therapeutics [Category] SARS, 변종, [키워드] 95% confidence interval Adults age analyses approval approved Attitude Canada Care change changed changes in children coronavirus disease country COVID-19 COVID-19 vaccine favor finding hospital less mother Odds ratio pandemic parent parental attitudes pediatric presenting Regulatory Research Support supported The United States the vaccine vaccination Vaccine Vaccine hesitancy vaccine research Year [DOI] 10.1016/j.clinthera.2021.11.003 [Article Type] Research article
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre studyObservational Study Published on 2022-01-012022-10-05 Journal: Clinical and experimental nephrology [Category] 임상, [키워드] Administered allergic BNT162b2 BNT162b2 vaccine clinically Control COVID-19 COVID-19 infection criteria death dialysis dose Efficiency eligible Enrollment ESRD Hemodialysis incidence Infection intramuscularly less life-threatening Local of BNT162b2 offer Patient patients primary end-point retrospective screened Severe COVID-19 Infection Side-effect single dose survival rate systemic reaction the vaccine unit vaccination Vaccine vaccine dose [DOI] 10.1007/s10157-021-02118-4 PMC 바로가기 [Article Type] Observational Study
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disordersResearch article Published on 2022-01-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] SARS, 진단, [키워드] adverse effect adverse events Belgrade case fatality ratio clinic Clinical characteristics clinical manifestation Cohort COVID COVID-19 COVID-19 in patient COVID-19 vaccine diagnosed with COVID-19 Diagnostic Criteria died disorder dose EDSS enrolled Hospitalization Hospitalized indicate information Invasive mechanical ventilation NEUROLOGY NMOSD outcome Patient patients Pfizer Pneumonia Prospective report requiring supplemental oxygen Result safety profile SARS-CoV-2 severity severity of COVID-19 Sinopharm the vaccine These data vaccination Vaccine [DOI] 10.1016/j.msard.2021.103320 [Article Type] Research article